| Literature DB >> 32922956 |
Ming Ge1, Qi Zeng2, Wei Yang1, Chenghao Chen2.
Abstract
BACKGROUND: Pleural-subarachnoid fistula (PSF) is a rare disease that is difficult to diagnose and treat. Secondary intracranial hypertension and the treatment are seldom mentioned previously among PSF. CASEEntities:
Keywords: Complications; Intracranial hypertension; Pleural-subarachnoid fistula; Treatment
Year: 2020 PMID: 32922956 PMCID: PMC7409484 DOI: 10.1186/s41016-020-00204-2
Source DB: PubMed Journal: Chin Neurosurg J ISSN: 2057-4967
Fig. 1a–c Brain CT and heavily T2 spine MR. a No abnormal signs on brain CT. b, c The arrow in heavily spine MR shows the suspected fistula signal between at T11 level
Fig. 2d–e Myelography. d–e The arrows show the contrast agents leaking from the subarachnoid space to the thorax
Fig. 3f–i Chest X-ray and brain MRI. f, g The MRIs show no ventriculomegaly or paraventricular edema after removal of cisternal drainage. h, i The chest X-ray show the no effusion in the thorax
Etiology of PSF
| Etiology | Percentage (number) |
|---|---|
| Iatrogenic | 51.8% (29) |
| Injury | 26.8% (15) |
| Car accident | 17.8% (10) |
| others | 3.6% (2) |
Manifestation of PSF
| Manifestation | Percentage (%) |
|---|---|
| Pleural effusion | 74.1 |
| Pneumocephalus | 10.3 |
| Hemopneumothorax | 8.6 |
| Postured headache | 5.3 |
| Upper mediastinum dilation | 1.7 |
Examination technique for diagnosis
| Examination technique | Positive rate (%) |
|---|---|
| Radioisotope myelography | 100 |
| Heavy T2-weighted myelography MR | 88.9 |
| β2 transferrin | 85.7 |
| CT myelography | 83.3 |
| Myelography | 66.7 |
Treatment of PSF
| Treatment | Percentage (%) |
|---|---|
| Surgery | 57.1 |
| Through thorax | 40.8 |
| Through laminar | 14.3 |
| Thorax-peritoneal shunt | 2.0 |
| Non-surgery | 42.9 |
| Drainage | 24.5 |
| NPPV | 10.2 |
| Injection of the biological glue | 4.1 |
| Epidural blood patch | 4.1 |